LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 1209 | 743 | 4121 | 0.1803 | -0.2408 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 1209 | 3704 | 3823 | 0.9689 | 0.9623 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 1209 | 3656 | 4093 | 0.8931 | 0.8754 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 1209 | 3636 | 4121 | 0.8823 | 0.8633 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 1209 | 3862 | 3823 | 1.0102 | 1.0123 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 1209 | 3664 | 4093 | 0.8950 | 0.8778 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 1209 | 3473 | 4121 | 0.8427 | 0.8156 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 1209 | 3701 | 3823 | 0.9681 | 0.9613 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 1209 | 3637 | 4093 | 0.8884 | 0.8699 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 1209 | 3831 | 4121 | 0.9296 | 0.9191 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 1209 | 2475 | 3823 | 0.6474 | 0.5392 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 1209 | 2978 | 4093 | 0.7274 | 0.6690 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 1209 | 2998 | 4121 | 0.7275 | 0.6707 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 1209 | 3245 | 3823 | 0.8488 | 0.8120 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 1209 | 3069 | 4093 | 0.7497 | 0.6978 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 1209 | 2946 | 4121 | 0.7148 | 0.6542 |
MCF7 | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 1209 | 956 | 3823 | 0.2501 | -0.1321 |
MCF7 | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 1209 | 852 | 4093 | 0.2081 | -0.1806 |
MCF7 | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 1209 | 960 | 4121 | 0.2329 | -0.1225 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 1209 | 2387 | 3823 | 0.6244 | 0.5060 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 1209 | 2315 | 4093 | 0.5655 | 0.4464 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 3 | H24 | 72 | hr | 1209 | 2437 | 4121 | 0.5913 | 0.4860 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 1209 | 2263 | 3823 | 0.5919 | 0.4584 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 1209 | 2082 | 4093 | 0.5086 | 0.3617 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 1209 | 2462 | 4121 | 0.5974 | 0.4946 |